North America Immune Health Supplements Market Size and Share

North America Immune Health Supplements Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

North America Immune Health Supplements Market Analysis by Mordor Intelligence

The North America immune health supplements market size was valued at USD 4.58 billion in 2025 and estimated to grow from USD 5.01 billion in 2026 to reach USD 7.81 billion by 2031, at a CAGR of 9.29% during the forecast period (2026-2031). An emphasis on preventive healthcare and wellness heavily influenced North America's dietary supplements market. While vitamins and minerals dominated the product landscape, probiotics emerged as a rapidly growing segment, fueled by heightened consumer awareness of gut and immune health. Probiotics, in particular, gained traction due to their perceived benefits in improving digestion, enhancing immunity, and addressing specific health concerns like irritable bowel syndrome (IBS). Tablets held the top spot in product format, but gummies surged in popularity, thanks to their palatable taste and ease of consumption. Gummies appealed to a broader demographic, including children and adults, who preferred a more enjoyable alternative to traditional pills. Specialty and health stores remained the go-to sales channels, yet online platforms saw a swift rise, capitalizing on convenience and data-driven customization. The U.S. commanded the largest market share, but Mexico surfaced as a notable growth hotspot. Factors like an aging population, a rise in chronic conditions, and a demand for premium, bioavailable products bolstered the market's expansion.

Key Report Takeaways

  • By product type, vitamins and minerals led with 31.48% the 2025 share; probiotics represent the fastest segment with a 9.42% CAGR to 2031.
  • By form, tablets captured 30.55% of the 2025 share, while gummies are set to grow at an 10.44% CAGR over the forecast period.
  • By distribution channel, specialty and health stores held 41.96% of the 2025 share, whereas online retail is expected to rise at a 10.08% CAGR through 2031.
  • By geography, the United States dominated with 78.65% of the 2025 share, whereas Mexico is projected to expand at an 10.86% CAGR during 2026-2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.

Segment Analysis

By Product Type: Vitamins and Minerals Lead, with Strong Growth in Probiotics

The vitamins and minerals segment dominated the North America immune health supplements market in 2025, accounting for 31.48% of revenue, driven by physician acceptance and comprehensive nutritional benefits. The probiotics segment is projected to grow at a 9.42% CAGR, gaining prominence as research advances in gut-immune system interactions. New probiotic strains, including Faecalibacterium duncaniae and Bacteroides dorei, demonstrate the industry's shift toward targeted immunity benefits. The market continues to evolve with the introduction of postbiotics and synbiotics in the "Others" category. Technical advances in microencapsulation technology improve probiotic survival rates in the digestive system, while liposomal delivery systems enhance vitamin absorption. The market supports premium pricing for products with strong scientific validation.

The market structure features strategic partnerships between ingredient suppliers, contract manufacturers, and finished-product companies. For example, Cargill's EpiCor postbiotic is now available in multiple product formats, including gummies, capsules, and powders, through various partnerships. Botanical extracts maintain a stable market presence among consumers seeking natural immunity solutions, while omega-3 products combine cardiovascular and immune health benefits. While probiotics demonstrate the highest growth rate, ongoing innovation across categories ensures vitamins remain fundamental to the North America immune health supplements market through 2030.

North America Immune Health Supplements Market: Market Share by Product Type, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
North America Immune Health Supplements Market: Market Share by Product Type, 2025

By Form: Gummies Revolutionize Supplement Delivery

Tablets hold a dominant 30.55% market share in 2025, driven by their cost-effectiveness, stability, and precise dosing capabilities that resonate with traditional supplement users. The gummies segment is growing at an 10.44% CAGR, supported by consumer preferences for palatable delivery formats and new technologies enabling reduced-sugar formulations. Capsules and softgels maintain their market position through effective ingredient protection and consumer association with pharmaceutical-grade quality. Powders attract consumers seeking flexible dosing options and quick dissolution, especially among protein-focused demographics.

Cold-set gelation technology has emerged as an energy-efficient manufacturing method for gummies, improving product quality and shelf life. Vegan gummy formulations meet the increasing demand for plant-based options by using alternative gelling agents that deliver consistent texture and stability. The "Others" category encompasses delivery formats such as functional beverages, chewable tablets, and sublingual formulations that offer enhanced bioavailability. Manufacturing processes now integrate HACCP guidelines while facilitating natural ingredient incorporation to meet consumer demand for clean-label products.

By Distribution Channel: Specialty Stores Lead Market Share While E-commerce Shows Rapid Growth

Specialty and health stores hold a 41.96% market share in 2025, driven by their ability to provide expert consultation and curated product selections that enhance consumer confidence in immune health purchases. The online retail segment is growing at 10.08% CAGR, supported by direct-to-consumer brands and subscription models that provide reliable product availability. While supermarkets and hypermarkets offer extensive consumer reach, they struggle with immune health product education and premium positioning. Pharmacies represent another significant distribution channel, benefiting from their proximity to healthcare providers and established consumer trust.

NOW Foods launched brick-and-mortar exclusive product sizes in March 2024, introducing 20 supplement formulations specifically for independent retailers to differentiate from online competitors. The growth in e-commerce enables targeted marketing and subscription services, with companies using consumer data to enhance product recommendations and customer retention. However, online platforms face heightened regulatory oversight regarding health claims, necessitating comprehensive compliance measures to prevent FDA enforcement. An omnichannel presence has become crucial as consumers conduct online research before making in-store purchases, particularly for premium immune health products where professional guidance provides additional value.

North America Immune Health Supplements Market: Market Share by Distribution Channels, 2025
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
North America Immune Health Supplements Market: Market Share by Distribution Channels, 2025

Geography Analysis

The United States anchored 78.65% of 2025 sales within the North America immune health supplements market, owing to high discretionary income, a mature retail ecosystem, and prolific clinical research that validates new actives. Chronic conditions afflict more than three-quarters of adults, sustaining year-round demand for immune fortification. The FDA supplies clear guidance on good manufacturing practice, which raises baseline quality and cements consumer confidence, allowing premium lines to flourish.

Canada contributes steady expansion as Health Canada’s Natural Health Products Regulations enforce strong safety standards yet offer a clear licensing roadmap. Natural product numbers serve as visible trust marks on pack, driving consumer purchase intent. National latitude-induced vitamin D deficiency shapes product portfolios toward higher dosing and fortified functional foods. Temporary exemptions from plain-language labeling rules until 2028 give firms breathing room to update packs without interrupting supply.

Mexico is the breakout territory, poised for an 10.86% CAGR. Rising middle-class affluence lifts supplemental spending, and COFEPRIS modernization expedites product registrations. Front-of-pack nutrient warnings may appear onerous, yet brands that formulate below critical thresholds gain a competitive halo. Geographic proximity to U.S. manufacturing hubs keeps logistics costs in check, while cultural openness to herbal remedies allows hybrid formulations that blend botanicals with clinical-grade micronutrients. Collectively, distinct regulatory and socioeconomic conditions across the three countries ensure that no single go-to-market blueprint suffices. Brands must localize compliance, messaging, and retail strategy to capture the full potential of the North America immune health supplements market size through 2030.

Regulatory Landscape

In the United States, immune health supplements are regulated as dietary supplements under DSHEA (1994) and overseen by the FDA. Companies must comply with Current Good Manufacturing Practice requirements for dietary supplements (21 CFR Part 111), and immune positioning typically relies on permissible structure/function claims (for example, language such as supporting normal immune function) rather than disease-related claims that can trigger drug classification.

In Canada, immune health supplements marketed as Natural Health Products (NHPs) fall under the Natural Health Products Regulations (SOR/2003-196) and Health Canada oversight through the Natural and Non-prescription Health Products Directorate (NNHPD), including product licensing (NPN) and site licensing. The Ministerial Exemption Order published March 7, 2025 extends the compliance date for updated NHP labelling requirements to June 21, 2028, which affects how manufacturers sequence label changes while maintaining continuity of supply.

Competitive Landscape

The North American immune health supplements market exhibits moderate fragmentation, creating a competitive environment where established pharmaceutical players like Bayer AG and Pfizer Inc. compete alongside specialized nutrition companies such as Herbalife Nutrition Ltd. and Amway Corp. This diverse competitive landscape drives innovation across multiple dimensions, including ingredient science, delivery technologies, and consumer engagement strategies. 

The market's competitive dynamics are increasingly shaped by scientific differentiation rather than merely marketing claims, with companies investing in clinical validation to substantiate efficacy. This science-driven approach is exemplified by Lallemand Health Solutions' distribution agreement with Kirin Holdings for Immuse, a postbiotic containing heat-inactivated Lactococcus lactis that has been validated through 15 clinical studies demonstrating enhanced immune responses in May 2025. Strategic consolidation continues to reshape the competitive landscape, with the May 2025 acquisition of The Vitamin Shoppe by Kingswood Capital Management and Performance Investment Partners highlighting the value of established retail distribution networks combined with digital capabilities. 

White-space opportunities exist in personalized immune support solutions, with over half of consumers expressing interest in genetic testing for nutrition guidance, indicating untapped potential for tailored formulations that address individual risk factors and health goals. Technological innovation represents another competitive frontier, with advances in delivery systems like lipid nanoparticles (LNPs) demonstrating potential to enhance the bioavailability and efficacy of immune ingredients, creating differentiation opportunities for companies that can successfully commercialize these technologies.

North America Immune Health Supplements Industry Leaders

  1. Pfizer Inc.

  2. Bayer AG

  3. Herbalife Nutrition Inc.

  4. Amway Corporation

  5. Nestle SA

  6. *Disclaimer: Major Players sorted in no particular order
North America Immune Health Supplements Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Market Opportunities and Future Outlook

Named, clinically supported, better-formulating ingredients remain a key whitespace for differentiation in immune health supplements, especially where brands need substantiated structure/function claims under FDA rules and comparable documentation for Health Canada NHP licensing. The market is also moving toward gut-immune axis platforms (postbiotics, targeted probiotic strains, synbiotics) and delivery technologies that improve survival and absorption, supporting premiumization in probiotics and related formats.

Two 2026 evidence points point to actionable opportunity areas around sustainable sourcing and new immune actives. Ingredion acquired Benicaros in June 2026, a prebiotic fiber derived from upcycled carrot pomace with clinical positioning around immune support, indicating expanding interest in upcycled, label-friendly functional fibers for immune formulations. Separately, ingredient and formulation work aimed at improving solubility and neutral flavor is widening the use of immune ingredients into drink mixes and functional beverages, aligning with the channel shift toward online and omnichannel discovery while keeping marketing within compliant, substantiated structure/function boundaries.

Recent Industry Developments

  • June 2026: Ingredion acquired Benicaros, a prebiotic fiber derived from upcycled carrot pomace positioned with clinical support for immune health. The acquisition strengthens Ingredion’s functional fiber portfolio and gives supplement formulators another branded, sustainability-linked option for gut-immune formulations.
  • May 2025: Pharmavite, a subsidiary of Otsuka, opened the Pharmavite New Albany facility in Ohio to manufacture Nature Made gummy supplements. The added gummy-focused capacity supports faster scale-up in a high-growth format and helps improve supply reliability for major retail and omnichannel programs.
  • December 2024: Nature's Bounty introduced a Plant-Based Omega-3 supplement sourced from algae as an alternative to fish oil. The launch expands omega-3 accessibility for vegetarian and non-fish consumers and reinforces the shift toward differentiated, preference-led immune-adjacent nutrition within mainstream supplement brands.

Table of Contents for North America Immune Health Supplements Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Preventive Healthcare Trends Strengthen Immune Supplement Market
    • 4.2.2 Growing Demand for Vitamin D Supplements Among Elderly for Bone Health
    • 4.2.3 Rising Chronic Disease Rates
    • 4.2.4 Increased Use of E-Commerce and DTC Brands
    • 4.2.5 Product Innovation and Use of Functional Ingredients
    • 4.2.6 Supportive Regulatory Landscape
  • 4.3 Market Restraints
    • 4.3.1 Stringent Labeling and Health Claims
    • 4.3.2 High Market Competition
    • 4.3.3 Risk of Overconsumption and Side Effects
    • 4.3.4 Availability of Alternatve Supplements
  • 4.4 Supply-Chain Analysis
  • 4.5 Technological Outlook
  • 4.6 Porter’s Five Forces
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS

  • 5.1 By Product Type
    • 5.1.1 Vitamins and Minerals
    • 5.1.2 Herbal/Botanical Extracts
    • 5.1.3 Probiotics
    • 5.1.4 Omega-3 Fatty Acids
    • 5.1.5 Others
  • 5.2 By Form
    • 5.2.1 Capsules and Softgels
    • 5.2.2 Tablets
    • 5.2.3 Gummies
    • 5.2.4 Powders
    • 5.2.5 Others
  • 5.3 By Distribution Channel
    • 5.3.1 Supermarkets/Hypermarkets
    • 5.3.2 Specialty and Health Stores
    • 5.3.3 Online Stores
    • 5.3.4 Other Distribution Channels
  • 5.4 By Geography
    • 5.4.1 United States
    • 5.4.2 Canada
    • 5.4.3 Mexico
    • 5.4.4 Rest of North America

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Positioning Analysis
  • 6.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)}
    • 6.4.1 Amway Corp (Nutrilite)
    • 6.4.2 BayerAG
    • 6.4.3 Herbalife Nutrition Ltd.
    • 6.4.4 DSM-Firmenich
    • 6.4.5 NOW Foods
    • 6.4.6 Glanbia plc
    • 6.4.7 Nestlé SA
    • 6.4.8 PfizerInc. (Emergen-C, Centrum)
    • 6.4.9 PharmaviteLLC (Nature Made)
    • 6.4.10 GNC HoldingsLLC
    • 6.4.11 Church & DwightCo.Inc. (Vitafusion)
    • 6.4.12 USANA Health Sciences
    • 6.4.13 Jamieson WellnessInc.
    • 6.4.14 Nature’s Way (Schwabe North America)
    • 6.4.15 The Himalayan Drug Company (Himalaya)
    • 6.4.16 Life Extension (LEF)
    • 6.4.17 Abbott Laboratories (Pedialyte Immune)
    • 6.4.18 BioGaiaAB
    • 6.4.19 Holland and Barret Inc.
    • 6.4.20 Vitabiotics

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Research Methodology Framework and Report Scope

Market Definition and Coverage

We define the market as retail and practitioner-sold dietary supplements in North America that are bought mainly for immune support, and we capture it in value terms across mainstream and specialty channels.

Scope exclusions: We exclude prescription medicines, vaccines, and clinical nutrition sold as regulated medical foods. We also exclude general foods and beverages that only carry an immunity claim.

Segmentation Overview

  • By Product Type
    • Vitamins and Minerals
    • Herbal/Botanical Extracts
    • Probiotics
    • Omega-3 Fatty Acids
    • Others
  • By Form
    • Capsules and Softgels
    • Tablets
    • Gummies
    • Powders
    • Others
  • By Distribution Channel
    • Supermarkets/Hypermarkets
    • Specialty and Health Stores
    • Online Stores
    • Other Distribution Channels
  • By Geography
    • United States
    • Canada
    • Mexico
    • Rest of North America

Data Sources, Market Sizing, and Validation

Desk Research

Desk research was used to set the market boundary and build the base demand pool for immune-focused supplements in the United States, Canada, and Mexico. We reviewed public health and nutrition references such as the NIH Office of Dietary Supplements, CDC publications, Health Canada guidance, and selected FDA dietary supplement and labeling pages, which helped clarify what is treated as a dietary supplement versus what is not.

To pressure-test the revenue logic, we also used sources such as U.S. Census retail trade context and national trade and customs statistics to understand ingredient and finished-goods movement, alongside peer-reviewed nutrition journals to map typical ingredient adoption patterns. Company filings, investor presentations, and reputable press were used to track mix shifts like gummies versus tablets and to check online share changes. Where needed, our internal paid subscriptions for company financials, patent databases, and an import-export shipment-level database were used to validate directional trends and fill gaps. This list is not exhaustive, and many other public and proprietary sources were also reviewed to collect data, validate assumptions, and clarify open questions.

Primary Interviews and Surveys

Primary work focused on validating what portion of total supplement sales is truly immune-positioned, and how pricing and promotions changed across countries and channels. We spoke with ingredient and finished-product stakeholders, channel specialists (online and brick-and-mortar), and subject experts tracking consumer health trends across North America. Their input helped us correct secondary-data gaps and confirm the final model outputs.

Distribution of primary research fieldwork respondents

Company type Respondent position Region
Top tier: 27% CXOs: 16%
Mid tier: 51% Functional/Unit leaders: 35%
Smaller Players: 22% Managers: 49%

Market-Sizing & Forecasting

Sizing starts from a top-down build where North America dietary supplement spending is narrowed using immune-claim incidence, product-category splits (such as vitamins and minerals, probiotics, botanicals, and omega-3), and channel mix across the United States, Canada, and Mexico. After that, we run selective bottom-up checks using sampled brand and channel price points, observed pack sizes, and volume proxies, so totals can be adjusted when the implied revenue per buyer looks unrealistic.

A few inputs that move the model include immune-claim product availability on shelves and online, average selling price progression by form (gummies typically price differently than tablets), online retail share gains, shifts in consumer preference toward probiotics and botanicals, and country-level differences in regulations and labeling norms. When granular data is missing, we don't force a full roll-up, and instead use conservative range estimates that are narrowed through channel checks and expert feedback.

For forecasting, we used scenario analysis tied to drivers that can be tracked each year, including supplement penetration, real pricing trends, and channel expansion. We then aligned those scenarios with what primary respondents expect on demand stability and promo intensity. The result is a forward view that stays explainable and can be updated with refreshed inputs as new public indicators become available.

Data Validation & Update Cycle

Model outputs are triangulated against independent signals such as category growth in broader supplements, channel-level momentum, and country splits that fit consumption and retail structures. We review outliers, revisit assumptions, and if variance remains high, we re-contact relevant experts to confirm whether the change reflects a real shift or data-driven noise.

Before sign-off, estimates go through a multi-step analyst review to check calculation logic, unit consistency, and currency handling again. Reports are refreshed annually, with interim updates made when material events occur, such as sharp pricing changes, regulatory shifts, or major channel disruptions. Right before delivery, we run a final pass to ensure the latest available updates are reflected in the numbers and narrative.

Mordor Intelligence's North America Immune Health Supplements Market Size Compared With Other Published Estimates

Published market values for immune health supplements can look far apart because the underlying scope can shift, even when the titles sound similar. The biggest swings usually come from what is counted as a supplement versus an immune-claim functional food, which countries are included, and whether the number is reported at retail value or at another point in the value chain.

The table shows a tight mid-single-digit billion range in one estimate versus much larger figures in others. In Mordor Intelligence's model, the North America total is limited to immune health supplements sold through defined supplement channels, and it excludes broader dietary supplements and immunity-positioned foods and drinks that can inflate totals when they get grouped together.

Benchmark comparison

Source Market Size Gaps in Research Methodology
Mordor Intelligence USD 4.58 B (2025)
Industry Research Publisher A USD 18.16 B (2025) This figure appears to use a wider definition that can bundle a broader supplement universe and related wellness categories under immunity, which increases the counted revenue pool beyond immune-positioned supplements.
Market Platform B USD 22.15 B (2022) This estimate is for an earlier year and the scope looks broader, with a higher chance of mixing immune health supplements with adjacent immunity-claimed products. Different pricing points and currency timing can further widen the gap.

Across the three figures, the spread is explained mostly by scope width, year alignment, and the pricing basis used to convert demand into revenue. By keeping the inputs tied to observable channel mix, form-level pricing, and clearly defined immune-positioned supplement categories, our estimate stays easier to reconcile and update when new signals show up.

Key Questions Answered in the Report

What is the current size of the North America immune health supplements market?

The market stands at USD 5.01 billion in 2026 and is projected to climb to USD 7.81 billion by 2031.

Which country contributes the largest share to regional sales?

The United States holds 78.65% of 2025 market share, reflecting mature retail infrastructure and high consumer spending.

Which product category is growing fastest?

Probiotics are forecast to advance at a 9.42% CAGR between 2026-2031, outpacing vitamins and minerals.

Why are gummies gaining popularity?

Gummies combine palatable taste with advanced gelation technology, driving an 10.44% CAGR from 2026 onward while maintaining functional efficacy.

Page last updated on:

North America Immune Health Supplements Report Snapshots